Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

3.605

-0.055 (-1.50%)

At close: Aug 26, 2026, 4:00 PM EDT

3.495

-0.110 (-3.05%)

Pre-market: Aug 27, 2026, 4:00 AM EDT

Anixa Biosciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	1.48	1.24	1.27	0.92	12.36	29.13
Short-Term Investments	12.21	13.93	18.65	22.93	17.33	6.6
Cash & Short-Term Investments	13.69	15.17	19.92	23.84	29.69	35.73
Cash Growth	-12.25%	-23.84%	-16.44%	-19.68%	-16.91%	294.47%
Other Receivables	0.06	-	0.17	0.27	0.05	-
Receivables	0.06	-	0.17	0.27	0.05	-
Prepaid Expenses	0.95	0.71	1.27	1.24	0.47	0.28
Total Current Assets	14.69	15.89	21.36	25.36	30.2	36
Property, Plant & Equipment	0.17	0.19	0.23	0.17	0.21	0.25
Total Assets	14.87	16.08	21.59	25.52	30.41	36.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Accounts Payable	0.25	0.17	0.53	0.21	0.27	0.14
Accrued Expenses	1.21	1.76	1.95	1.77	1.73	1.1
Current Portion of Leases	0.04	0.04	0.03	0.05	0.05	0.04
Total Current Liabilities	1.5	1.97	2.5	2.03	2.04	1.27
Long-Term Leases	0.14	0.16	0.2	0.12	0.18	0.22
Total Liabilities	1.64	2.13	2.7	2.15	2.21	1.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Common Stock	0.34	0.33	0.32	0.31	0.31	0.3
Additional Paid-In Capital	270.89	266.51	260.43	252.22	247.12	239.93
Retained Earnings	-256.76	-251.68	-240.75	-228.2	-218.39	-204.79
Treasury Stock	-	-	-0.01	-	-	-
Total Common Equity	14.48	15.16	20	24.34	29.05	35.44
Minority Interest	-1.25	-1.21	-1.11	-0.97	-0.85	-0.67
Shareholders' Equity	13.22	13.95	18.89	23.37	28.2	34.77
Total Liabilities & Equity	14.87	16.08	21.59	25.52	30.41	36.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Total Debt	0.18	0.2	0.23	0.18	0.22	0.26
Net Cash (Debt)	13.5	14.97	19.69	23.67	29.47	35.47
Net Cash Growth	-12.19%	-23.98%	-16.80%	-19.67%	-16.92%	294.01%
Net Cash Per Share	0.41	0.46	0.62	0.76	0.97	1.24
Filing Date Shares Outstanding	34.02	33.38	32.19	31.7	30.92	30.13
Total Common Shares Outstanding	33.92	33.01	32.19	31.15	30.91	30.05
Working Capital	13.19	13.92	18.86	23.33	28.16	34.73
Book Value Per Share	0.43	0.46	0.62	0.78	0.94	1.18
Tangible Book Value	14.48	15.16	20	24.34	29.05	35.44
Tangible Book Value Per Share	0.43	0.46	0.62	0.78	0.94	1.18

SEC Filings: 10-K · 10-Q